Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Impact on brown adipose tissue: Berberine may lower weight by increasing brown adipose tissue, a type of fat tissue that ...

Semaglutide for weight loss is given as a subcutaneous injection ... of up to eight percent due to gastrointestinal side effects. Some research suggests discontinuation rates for GLP-1s may ...

Fortunately, so much research has come out about diabetes and weight-loss drugs like Ozempic and Wegovy that we know ...

The researchers behind the study postulated that 93 million US adults may be suitable for semaglutide treatment ... to question whether these drugs have a sustained effect on weight loss. Research ...

A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

The search for effective weight loss solutions has led to countless diet trends, fitness regimens, and medical interventions.

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

The ad criticizes the $160 billion weight loss industry ... "knockoff versions of semaglutide – a drug that was formulated by Novo Nordisk following decades of research and billions in ...